MFDS — authorised 21 December 2012
- Marketing authorisation holder: AEGERION
- Status: likely_approved
🇰🇷 Juxtapid in South Korea
MFDS authorised Juxtapid on 21 December 2012
Marketing authorisation
Juxtapid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Juxtapid approved in South Korea?
Yes. MFDS authorised it on 21 December 2012.
Who is the marketing authorisation holder for Juxtapid in South Korea?
AEGERION holds the South Korean marketing authorisation.